Mutants of protein kinase a that mimic the ATP-binding site of protein kinase B (AKT)

被引:50
作者
Gassel, M
Breitenlechner, CB
Rüger, P
Jucknischke, U
Schneider, T
Huber, R
Bossemeyer, D
Engh, RA
机构
[1] German Canc Res Ctr, DKFZ, Div Pathochem, D-69120 Heidelberg, Germany
[2] Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany
[3] Roche Diagnost GmbH, Pharmaceut Res, D-82377 Penzberg, Germany
关键词
PKA; PKB; protein kinase; crystal structure; point mutation;
D O I
10.1016/S0022-2836(03)00518-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mutation of well behaved enzymes in order to simulate less manageable cognates is the obvious approach to study specific features of the recalcitrant target. Accordingly, the prototypical protein kinase PKA serves as a model for many kinases, including the closely related PKB, an AGC family protein kinase now implicated as oncogenic in several cancers. Two residues that differ between the alpha isoforms of PKA and PKB at the adenine-binding site generate differing shapes of the binding surface and are likely to play a role in ligand selectivity. As the corresponding mutations in PKA, V123A would enlarge the adenine pocket, while L173M would alter both the shape and its electronic character of the adenine-binding surface. We have determined the structures of the corresponding double mutant (PKAB2: PKAalpha V123A, L173M) in apo and MgATP-bound states, and observed structural alterations of a residue not previously involved in ATP-binding interactions: the side-chain of Q181, which in native PKA points away from the ATP-binding site, adopts in apo double mutant protein a new rotamer conformation, which places the polar groups at the hinge region in the ATP pocket. MgATP binding forces Q181 back to the position seen in native PKA. The crystal structure shows that ATP binding geometry is identical with that in native PKA but in this case was determined under conditions with only a single Mg ion ligand. Surface plasmon resonance spectroscopy studies show that significant energy is required for this ligand-induced transition. An additional PKA/PKB mutation, Q181K, corrects the defect, as shown both by the crystal structure of triple mutant PKAB3 (PKAalpha V123A, L173M, Q181K) and by surface plasmon resonance spectroscopy binding studies with ATP and three isoquinoline inhibitors. Thus, the triple mutant serves well as an easily crystallizable model for PKB inhibitor interactions. Further, the phenomenon of Q181 shows how crystallographic analysis should accompany mutant studies to monitor possible spurious structural effects. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1021 / 1034
页数:14
相关论文
共 38 条
[1]   VASODILATOR ACTIONS OF HA1077 INVITRO AND INVIVO PUTATIVELY MEDIATED BY THE INHIBITION OF PROTEIN-KINASE [J].
ASANO, T ;
SUZUKI, T ;
TSUCHIYA, M ;
SATOH, S ;
IKEGAKI, I ;
SHIBUYA, M ;
SUZUKI, Y ;
HIDAKA, H .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (04) :1091-1100
[2]   PHOSPHOTRANSFERASE AND SUBSTRATE BINDING MECHANISM OF THE CAMP-DEPENDENT PROTEIN-KINASE CATALYTIC SUBUNIT FROM PORCINE HEART AS DEDUCED FROM THE 2.0 ANGSTROM STRUCTURE OF THE COMPLEX WITH MN2+ ADENYLYL IMIDODIPHOSPHATE AND INHIBITOR PEPTIDE PKI(5-24) [J].
BOSSEMEYER, D ;
ENGH, RA ;
KINZEL, V ;
PONSTINGL, H ;
HUBER, R .
EMBO JOURNAL, 1993, 12 (03) :849-859
[3]   THE GLYCINE-RICH SEQUENCE OF PROTEIN-KINASES - A MULTIFUNCTIONAL ELEMENT [J].
BOSSEMEYER, D .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (05) :201-205
[4]  
Brognard J, 2001, CANCER RES, V61, P3986
[5]   Protein kinases - the major drug targets of the twenty-first century? [J].
Cohen, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :309-315
[6]   Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89 - Structural implications for selectivity [J].
Engh, RA ;
Girod, A ;
Kinzel, V ;
Huber, R ;
Bossemeyer, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (42) :26157-26164
[7]   Structural aspects of protein kinase control - role of conformational flexibility [J].
Engh, RA ;
Bossemeyer, D .
PHARMACOLOGY & THERAPEUTICS, 2002, 93 (2-3) :99-111
[8]   A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase [J].
Fox, T ;
Coll, JT ;
Xie, XL ;
Ford, PJ ;
Germann, UA ;
Porter, MD ;
Pazhanisamy, S ;
Fleming, MA ;
Galullo, V ;
Su, MSS ;
Wilson, KP .
PROTEIN SCIENCE, 1998, 7 (11) :2249-2255
[9]   In vivo activation of recombinant cAPK catalytic subunit active site mutants by coexpression of the wild-type enzyme, evidence for intermolecular cotranslational phosphorylation [J].
Girod, A ;
Kinzel, V ;
Bossemeyer, D .
FEBS LETTERS, 1996, 391 (1-2) :121-125
[10]   ISOQUINOLINESULFONAMIDES, NOVEL AND POTENT INHIBITORS OF CYCLIC-NUCLEOTIDE DEPENDENT PROTEIN-KINASE AND PROTEIN KINASE-C [J].
HIDAKA, H ;
INAGAKI, M ;
KAWAMOTO, S ;
SASAKI, Y .
BIOCHEMISTRY, 1984, 23 (21) :5036-5041